Dashboard
Manage Tickers

ARHSArhaus, Inc.

Nasdaq arhaus.com


$ 16.41 $ -0.58 (-3.41 %)    

Wednesday, 17-Jul-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.23 $ -14.57 (-2.94 %)
DIA $ 412.29 $ 2.27 (0.55 %)
SPY $ 557.05 $ -7.92 (-1.4 %)
TLT $ 94.21 $ 0.02 (0.02 %)
GLD $ 227.29 $ -1.06 (-0.46 %)
$ 16.41
$ 16.72
$ 0.00 x 0
$ 0.00 x 0
$ 16.24 - $ 17.01
$ 7.31 - $ 19.81
839,459
na
2.31B
$ 2.04
$ 21.71
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 12-09-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

arhaus-and-rh-distinguished-by-premium-focus-scale-and-national-networks---analyst-initiates-coverage
Arhaus And RH Distinguished By Premium Foc...
07/09/2024 18:49:04

Analyst initiates coverage on Arhaus and RH, highlighting Arhaus' growth potential and RH's compelling valuation amidst...

stifel-initiates-coverage-on-arhaus-with-buy-rating-announces-price-target-of-195
Stifel Initiates Coverage On Arhaus with B...
07/09/2024 10:01:31

Stifel analyst W. Andrew Carter initiates coverage on Arhaus (NASDAQ:ARHS) with a Buy rating and announces Price Target of $...

why-arhaus-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Arhaus Shares Are Trading Lower By Aro...
07/08/2024 17:16:55

jefferies-downgrades-arhaus-to-hold-lowers-price-target-to-16
Jefferies Downgrades Arhaus to Hold, Lower...
07/08/2024 12:56:30

Jefferies analyst Jonathan Matuszewski downgrades Arhaus (NASDAQ:ARHS) from Buy to Hold and lowers the price target from $22...

expert-ratings-for-arhaus
Expert Ratings For Arhaus
05/20/2024 14:01:34

td-cowen-maintains-buy-on-arhaus-raises-price-target-to-19
TD Cowen Maintains Buy on Arhaus, Raises P...
05/20/2024 13:13:49

TD Cowen analyst Max Rakhlenko maintains Arhaus (NASDAQ:ARHS) with a Buy and raises the price target from $18 to $19.

piper-sandler-reiterates-overweight-on-arhaus-raises-price-target-to-20
Piper Sandler Reiterates Overweight on Arh...
05/10/2024 13:38:41

Piper Sandler analyst Peter Keith reiterates Arhaus (NASDAQ:ARHS) with a Overweight and raises the price target from $19 to ...

baird-maintains-outperform-on-arhaus-raises-price-target-to-18
Baird Maintains Outperform on Arhaus, Rais...
05/10/2024 10:44:05

Baird analyst Peter Benedict maintains Arhaus (NASDAQ:ARHS) with a Outperform and raises the price target from $16 to $18.

12-consumer-discretionary-stocks-moving-in-thursdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
05/09/2024 16:31:14

telsey-advisory-group-maintains-outperform-on-arhaus-maintains-17-price-target
Telsey Advisory Group Maintains Outperform...
05/09/2024 13:38:09

Telsey Advisory Group analyst Joseph Feldman maintains Arhaus (NASDAQ:ARHS) with a Outperform and maintains $17 price target.

arhaus-q1-2024-gaap-eps-011-beats-003-estimate-sales-295162m-beat-264297m-estimate
Arhaus Q1 2024 GAAP EPS $0.11 Beats $0.03 ...
05/09/2024 10:38:02

Arhaus (NASDAQ:ARHS) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.03 by 266.6...

assessing-arhaus-insights-from-11-financial-analysts
Assessing Arhaus: Insights From 11 Financi...
04/26/2024 12:01:28

telsey-advisory-group-maintains-outperform-on-arhaus-maintains-17-price-target
Telsey Advisory Group Maintains Outperform...
04/26/2024 10:05:13

Telsey Advisory Group analyst Joseph Feldman maintains Arhaus (NASDAQ:ARHS) with a Outperform and maintains $17 price target.

rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday
REX American Resources Reports Upbeat Earn...
03/28/2024 15:00:16

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

b-of-a-securities-maintains-buy-on-arhaus-raises-price-target-to-17
B of A Securities Maintains Buy on Arhaus,...
03/20/2024 11:07:57

B of A Securities analyst Curtis Nagle maintains Arhaus (NASDAQ:ARHS) with a Buy and raises the price target from $14.5 to $17.

craig-hallum-maintains-buy-on-arhaus-raises-price-target-to-21
Craig-Hallum Maintains Buy on Arhaus, Rais...
03/08/2024 16:11:33

Craig-Hallum analyst Jeremy Hamblin maintains Arhaus (NASDAQ:ARHS) with a Buy and raises the price target from $14 to $21.

piper-sandler-reiterates-overweight-on-arhaus-raises-price-target-to-19
Piper Sandler Reiterates Overweight on Arh...
03/08/2024 14:55:18

Piper Sandler analyst Peter Keith reiterates Arhaus (NASDAQ:ARHS) with a Overweight and raises the price target from $15 to ...

jefferies-maintains-buy-on-arhaus-raises-price-target-to-17
Jefferies Maintains Buy on Arhaus, Raises ...
03/08/2024 13:18:36

Jefferies analyst Jonathan Matuszewski maintains Arhaus (NASDAQ:ARHS) with a Buy and raises the price target from $12 to $17.

baird-maintains-outperform-on-arhaus-raises-price-target-to-16
Baird Maintains Outperform on Arhaus, Rais...
03/08/2024 12:06:06

Baird analyst Peter Benedict maintains Arhaus (NASDAQ:ARHS) with a Outperform and raises the price target from $13 to $16.

demystifying-arhaus-insights-from-5-analyst-reviews
Demystifying Arhaus: Insights From 5 Analy...
03/08/2024 12:01:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)